These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24167638)

  • 1. Adeno-associated virus mediated delivery of a non-membrane targeted human soluble CD59 attenuates some aspects of diabetic retinopathy in mice.
    Adhi M; Cashman SM; Kumar-Singh R
    PLoS One; 2013; 8(10):e79661. PubMed ID: 24167638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non membrane-targeted human soluble CD59 attenuates choroidal neovascularization in a model of age related macular degeneration.
    Cashman SM; Ramo K; Kumar-Singh R
    PLoS One; 2011 Apr; 6(4):e19078. PubMed ID: 21552568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complement regulatory protein CD59: insights into attenuation of choroidal neovascularization.
    Schnabolk G; Tomlinson S; Rohrer B
    Adv Exp Med Biol; 2014; 801():435-40. PubMed ID: 24664728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable inhibition of choroidal neovascularization by adeno-associated virus 2/8-vectored bispecific molecules.
    Bai T; Cui B; Xing M; Chen S; Zhu Y; Lin D; Guo Y; Du M; Wang X; Zhou D; Yan H
    Gene Ther; 2024 Sep; 31(9-10):511-523. PubMed ID: 38961279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1.
    Díaz-Lezama N; Wu Z; Adán-Castro E; Arnold E; Vázquez-Membrillo M; Arredondo-Zamarripa D; Ledesma-Colunga MG; Moreno-Carranza B; Martinez de la Escalera G; Colosi P; Clapp C
    Lab Invest; 2016 Mar; 96(3):283-95. PubMed ID: 26568297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subretinal delivery of AAV2-mediated human erythropoietin gene is protective and safe in experimental diabetic retinopathy.
    Xu H; Zhang L; Gu L; Lu L; Gao G; Li W; Xu G; Wang J; Gao F; Xu JY; Yao J; Wang F; Zhang J; Xu GT
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1519-30. PubMed ID: 24508793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoinhibin gene transfer by adenoassociated virus type 2 protects against VEGF- and diabetes-induced retinal vasopermeability.
    Ramírez M; Wu Z; Moreno-Carranza B; Jeziorski MC; Arnold E; Díaz-Lezama N; Martínez de la Escalera G; Colosi P; Clapp C
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8944-50. PubMed ID: 22003113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59.
    Leaderer D; Cashman SM; Kumar-Singh R
    J Gene Med; 2015; 17(6-7):101-15. PubMed ID: 25917932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of complement membrane attack complex in dry and wet AMD - From hypothesis to clinical trials.
    Kumar-Singh R
    Exp Eye Res; 2019 Jul; 184():266-277. PubMed ID: 31082363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intravitreal injection of human CD34
    Yazdanyar A; Zhang P; Dolf C; Smit-McBride Z; Cary W; Nolta JA; Zawadzki RJ; Marsh-Armstrong N; Park SS
    Exp Eye Res; 2020 Jan; 190():107865. PubMed ID: 31682846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement regulatory protein CD59a plays a protective role in immune liver injury of trichloroethylene-sensitized BALB/c mice.
    Wang X; Yu Y; Xie HB; Shen T; Zhu QX
    Ecotoxicol Environ Saf; 2019 May; 172():105-113. PubMed ID: 30685621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of the gene encoding CD59a in mice increases disease severity in a murine model of rheumatoid arthritis.
    Williams AS; Mizuno M; Richards PJ; Holt DS; Morgan BP
    Arthritis Rheum; 2004 Sep; 50(9):3035-44. PubMed ID: 15457473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal Administration of AAV2-SIRT1 Reverses Diabetic Retinopathy in a Mouse Model of Type 2 Diabetes.
    Adu-Agyeiwaah Y; Vieira CP; Asare-Bediako B; Li Calzi S; DuPont M; Floyd J; Boye S; Chiodo V; Busik JV; Grant MB
    Transl Vis Sci Technol; 2023 Apr; 12(4):20. PubMed ID: 37070938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of adenovirus-delivered human CD59 as a potential therapy for AMD in a model of human membrane attack complex formation on murine RPE.
    Ramo K; Cashman SM; Kumar-Singh R
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4126-36. PubMed ID: 18487376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of the complement regulatory protein CD59 accelerates the development of diabetes-induced atherosclerosis in mice.
    Liu F; Sahoo R; Ge X; Wu L; Ghosh P; Qin X; Halperin JA
    J Diabetes Complications; 2017 Feb; 31(2):311-317. PubMed ID: 27729184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced recombinant adeno-associated virus-mediated vascular endothelial growth factor expression in the adult mouse retina: a potential model for diabetic retinopathy.
    Rakoczy PE; Brankov M; Fonceca A; Zaknich T; Rae BC; Lai CM
    Diabetes; 2003 Mar; 52(3):857-63. PubMed ID: 12606531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicle-Induced Classical Complement Activation Leads to Retinal Endothelial Cell Damage via MAC Deposition.
    Huang C; Fisher KP; Hammer SS; Busik JV
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Insights on Complement Inhibitor CD59 in Mouse Laser-Induced Choroidal Neovascularization: Mislocalization After Injury and Targeted Delivery for Protein Replacement.
    Schnabolk G; Beon MK; Tomlinson S; Rohrer B
    J Ocul Pharmacol Ther; 2017 Jun; 33(5):400-411. PubMed ID: 28333572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal AAV2.COMP-Ang1 Attenuates Deep Capillary Plexus Expansion in the Aged Diabetic Mouse Retina.
    Carroll LS; Uehara H; Fang D; Choi S; Zhang X; Singh M; Sandhu Z; Cummins PM; Curtis TM; Stitt AW; Archer BJ; Ambati BK
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2494-2502. PubMed ID: 31185088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical protection from renal ischemia reperfusion injury by CD55 and CD59.
    Yamada K; Miwa T; Liu J; Nangaku M; Song WC
    J Immunol; 2004 Mar; 172(6):3869-75. PubMed ID: 15004194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.